Treatment Options for Later-Stage Melanoma
NYU Langone medical oncologist Dr. Anna C. Pavlick discusses the different treatment options for stage 4 melanoma.
Treatment Progress Assessment-8 (TPA8) Manual
Treatment Progress Assessment-8 (TPA8) Manual 2 V3 4/19/21 Table of Contents Treatment Progress Assessment-8 ... Department of Population Health
Treatment Relieves Fibroid Symptoms Patient Had for a Decade
After enduring multiple surgeries and debilitating symptoms, Lauren Mims found renewed hope at NYU Langone’s Center for Fibroid Care.
Treatment-Resistant Coronavirus Found in Transplant Patients
An NYU Langone study finds mutated coronavirus that can escape the antiviral therapy remdesivir in two people with kidney transplants.
Treatments Are Advancing for Triple-Negative Breast Cancer
Dr. Sylvia Adams, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, discusses new treatments for triple-negative breast cancer.
Treatments Didn’t Reduce Cardiac Events in CKD Patients
NYU Grossman School of Medicine researchers found stents or bypass surgery didn’t lower rate of heart events in chronic kidney disease patients.
Treatments Target HER2-Positive Non-Small Cell Lung Cancer
Medical oncologists at NYU Langone’s Perlmutter Cancer Center discuss treatments for non-small cell lung cancer with HER2 mutation.
Trial Explores Invasive Strategy for Stable Heart Disease
NYU Langone’s Dr. Judith Hochman and colleagues find an invasive approach brings no added benefit for preventing a major cardiovascular event.
Trial Tests Personalized Metastatic Melanoma Vaccine
Dr. Jeffrey S. Weber, deputy director of NYU Langone’s Perlmutter Cancer Center, is testing a personalized mRNA vaccine for metastatic melanoma.
Trials Aim to Treat Bladder Cancer Without Bladder Removal
Dr. Scot Niglio, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, aims to avoid bladder removal in people with bladder cancer.